ArticleCell death & disease2018

A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma.

Berglind O Einarsdottir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.